Sarcopenia and Adverse Health-related Outcomes: An Umbrella Review of Meta-analyses of Observational Studies

Overview

Journal Cancer Med

Specialty Oncology

Date 2020 Sep 14

PMID 32924316

Citations 110

Authors

Lin Xia

Rui Zhao

Qianyi Wan

Yutao Wu

Yong Zhou

Yong Wang

Yaping Cui

Xiaoding Shen

Xiaoting Wu

Affiliations

Soon will be listed here.

Abstract

Objective: The purpose of this umbrella review was to assess the associations between sarcopenia and adverse health-related outcomes.

Design: An umbrella review of meta-analyses of observational studies.

Setting And Participants: Patients with sarcopenia and controls without sarcopenia were included.

Measures: The PubMed, Web of Science and Embase were searched for relevant systematic review and meta-analysis. AMSTAR and GRADE system were used for methodological quality and evidence quality assessments, respectively.

Results: Totally 54 outcomes extracted from 30 meta-analyses were analyzed. Twenty out of 21 prognostic outcomes indicated that sarcopenia was significantly associated with poorer prognosis of gastric cancer, hepatocellular cancer, urothelial cancer, head and neck cancer, hematological malignancy, pancreatic cancer, breast cancer, colorectal cancer, lung cancer, esophageal cancer, and ovarian cancer. Besides, 10 out of 16 postoperative outcomes suggested that sarcopenia significantly increased the risk of multiple postoperative complications and prolonged the length of hospitalization of patients with digestive cancer. In age-related outcomes, sarcopenia significantly increased the risk of dysphagia, cognitive impairment, fractures, falls, hospitalization, and all-cause mortality of elderly populations. Moreover, sarcopenia was also associated with higher level of albuminuria, risk of depression, and several metabolic diseases.

Conclusions And Implications: Sarcopenia significantly affected a wide range of adverse health-related outcomes, particularly in patients of tumor and elderly populations. Because evidences of most outcomes were rated as "low" and "very low," more prospective cohort studies are required in the future.

Citing Articles

The adipokines in oral cancer pathogenesis and its potential as a new therapeutic approach.

Wang X, Wang J, Zhao X, Zhang J, Zhang Y Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40056203 DOI: 10.1007/s00210-025-03939-w.

Prediction of sarcopenia at different time intervals: an interpretable machine learning analysis of modifiable factors.

Chen X, Li L BMC Geriatr. 2025; 25(1):133.

PMID: 40016704 PMC: 11866656. DOI: 10.1186/s12877-025-05792-1.

Machine learning based on nutritional assessment to predict adverse events in older inpatients with possible sarcopenia.

Liu C, Huang H, Chen M, Zhu M, Yu J Aging Clin Exp Res. 2025; 37(1):48.

PMID: 39985661 PMC: 11846711. DOI: 10.1007/s40520-024-02916-2.

Development of an artificial intelligence-based application for the diagnosis of sarcopenia: a retrospective cohort study using the health examination dataset.

Jeong C, Lim D, Noh S, Lee S, Park C BMC Med Inform Decis Mak. 2025; 25(1):61.

PMID: 39910567 PMC: 11796039. DOI: 10.1186/s12911-025-02900-4.

Ginsenoside Rc prevents dexamethasone-induced muscle atrophy and enhances muscle strength and motor function.

Kim A, Park S, Kim N, Park M, Cha S J Ginseng Res. 2025; 49(1):42-52.

PMID: 39872283 PMC: 11764205. DOI: 10.1016/j.jgr.2024.09.002.

References

Ubachs J, Ziemons J, Minis-Rutten I, Kruitwagen R, Kleijnen J, Lambrechts S . Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019; 10(6):1165-1174. PMC: 6903439. DOI: 10.1002/jcsm.12468. View

Su H, Ruan J, Chen T, Lin E, Shi L . CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging. 2019; 19(1):82. PMC: 6892174. DOI: 10.1186/s40644-019-0270-0. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Shea B, Grimshaw J, Wells G, Boers M, Andersson N, Hamel C . Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; 7:10. PMC: 1810543. DOI: 10.1186/1471-2288-7-10. View

Hu X, Dou W, Shao Y, Liu J, Xiong S, Yang W . The prognostic value of sarcopenia in patients with surgically treated urothelial carcinoma: A systematic review and meta-analysis. Eur J Surg Oncol. 2019; 45(5):747-754. DOI: 10.1016/j.ejso.2019.03.003. View

Wong A, Zhu D, Kraus D, Tham T . Radiologically Defined Sarcopenia Affects Survival in Head and Neck Cancer: A Meta-Analysis. Laryngoscope. 2020; 131(2):333-341. DOI: 10.1002/lary.28616. View

Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H . Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res. 2018; 48(11):893-904. DOI: 10.1111/hepr.13192. View

Yang Z, Zhou X, Ma B, Xing Y, Jiang X, Wang Z . Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic Review. J Gastrointest Surg. 2018; 22(11):1890-1902. DOI: 10.1007/s11605-018-3856-0. View

Martone A, Bianchi L, Abete P, Bellelli G, Bo M, Cherubini A . The incidence of sarcopenia among hospitalized older patients: results from the Glisten study. J Cachexia Sarcopenia Muscle. 2017; 8(6):907-914. PMC: 5700449. DOI: 10.1002/jcsm.12224. View

10.

Zhang X, Huang P, Dou Q, Wang C, Zhang W, Yang Y . Falls among older adults with sarcopenia dwelling in nursing home or community: A meta-analysis. Clin Nutr. 2019; 39(1):33-39. DOI: 10.1016/j.clnu.2019.01.002. View

11.

Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X . Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis. 2018; 33(10):1419-1427. DOI: 10.1007/s00384-018-3128-1. View

12.

Hanach N, McCullough F, Avery A . The Impact of Dairy Protein Intake on Muscle Mass, Muscle Strength, and Physical Performance in Middle-Aged to Older Adults with or without Existing Sarcopenia: A Systematic Review and Meta-Analysis. Adv Nutr. 2019; 10(1):59-69. PMC: 6370271. DOI: 10.1093/advances/nmy065. View

13.

Xia L, Zhao R, Wan Q, Wu Y, Zhou Y, Wang Y . Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies. Cancer Med. 2020; 9(21):7964-7978. PMC: 7643685. DOI: 10.1002/cam4.3428. View

14.

Zhang H, Lin S, Gao T, Zhong F, Cai J, Sun Y . Association between Sarcopenia and Metabolic Syndrome in Middle-Aged and Older Non-Obese Adults: A Systematic Review and Meta-Analysis. Nutrients. 2018; 10(3). PMC: 5872782. DOI: 10.3390/nu10030364. View

15.

Bear D, Langan A, Dimidi E, Wandrag L, Harridge S, Hart N . β-Hydroxy-β-methylbutyrate and its impact on skeletal muscle mass and physical function in clinical practice: a systematic review and meta-analysis. Am J Clin Nutr. 2019; 109(4):1119-1132. DOI: 10.1093/ajcn/nqy373. View

16.

Veronese N, Demurtas J, Soysal P, Smith L, Torbahn G, Schoene D . Sarcopenia and health-related outcomes: an umbrella review of observational studies. Eur Geriatr Med. 2021; 10(6):853-862. DOI: 10.1007/s41999-019-00233-w. View

17.

Deng H, Zha P, Peng L, Hou L, Huang K, Li X . Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. Dis Esophagus. 2018; 32(3). DOI: 10.1093/dote/doy115. View

18.

Belbasis L, Bellou V, Evangelou E, Ioannidis J, Tzoulaki I . Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015; 14(3):263-73. DOI: 10.1016/S1474-4422(14)70267-4. View

19.

Zhang X, Wang C, Dou Q, Zhang W, Yang Y, Xie X . Sarcopenia as a predictor of all-cause mortality among older nursing home residents: a systematic review and meta-analysis. BMJ Open. 2018; 8(11):e021252. PMC: 6252774. DOI: 10.1136/bmjopen-2017-021252. View

20.

Smith G, Julliand S, Reeds D, Sinacore D, Klein S, Mittendorfer B . Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr. 2015; 102(1):115-22. PMC: 4480667. DOI: 10.3945/ajcn.114.105833. View